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Editorial on the Research Topic
Developmental Abnormalities of Serotonin Homeostasis in Behavioral and Metabolic
Disorders: From Epigenetic Mechanisms to Protein Function
Serotonin (5-hydroxytryptamine, 5-HT) is a phylogenetically ancient signaling molecule with
pleiotropic effects in vertebrate organisms (Nardi et al., 2017). In the central nervous system,
it regulates developmental processes (Kepser and Homberg, 2015), and modulates integrative
functions and states, such as mood, anxiety, stress, aggression, sexual behavior, and cognition
(Olivier, 2014). Outside the nervous system, it exerts hormonal and paracrine/autocrine actions
by activating 5-HT receptors in various somatic tissues (Amireault et al., 2013). Both, central
and peripheral serotonin act on multiple metabolic organs in order to maintain systemic energy
homeostasis (Donovan and Tecott, 2013; Yabut et al., 2019). Although serotonin has been widely
studied as a suspect in behavioral and metabolic disorders, the relationship between 5-HT
disturbances in peripheral and central compartments has not been completely resolved, the
causal role of the observed 5-HT alterations in the etiology of various disorders has not been
fully established, and the molecular substrates of improper expression and function of proteins
regulating 5-HT signaling have not been entirely identified. These issues are addressed in the
current Research Topic by five papers employing various research methods on different vertebrate
organisms, with a common goal of untangling the link between developmental abnormalities of
serotonin homeostasis and behavioral and/or metabolic alterations in adult life.
Keeping in mind that 5-HT has a prominent role in prenatal programing of the
hypothalamo–pituitary–adrenal axis, Vera-Chang et al. explored the hypothesis that
exposure to the 5-HT reuptake blocker fluoxetine (FLX), a widely used antidepressant,
during the early or late period of sexual development impairs the stress axis of
adult zebrafish (Danio rerio), consequently disrupting their behavioral responses in a
sex- and time-dependent manner. Significantly lower stress-induced whole-body cortisol
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levels were observed in FLX-treated vs. control animals, and in
females vs. males. In addition, late FLX-treated females showed
increased, while early FLX-treated males showed decreased
exploratory behavior compared to controls of the same sex.
The results of this study point to the importance of sex-
and timing-based approaches to FLX treatment, warn of the
possible behavioral effects of FLX on adults exposed during fetal
development, and show the potential impact of FLX on aquatic
species in environments receiving sewage effluents.
Building upon evidence of the involvement of 5-HT
disfunction in the etiology of autism spectrum disorders (ASD),
Chakraborti et al. investigated the relationship between blood
5-HT parameters and severity of behavioral symptoms, as
well as gender effect on both measures. Lower platelet levels
of 5-HT and its metabolite 5-hydroxyindole acetic acid (5-
HIAA) in control males compared to females, a male-specific
increase in 5-HTmeasures correlating with increased intellectual
disability in ASD probands, and the presence of milder ASD
symptoms in males than in females suggest higher vulnerability
and a lower threshold for behavioral expression of ASD in
boys. The study highlights a gender-specific regulation of
platelet 5-HT homeostasis and its differential contribution
to behavioral expression of ASD in males and females,
partially explaining the higher male to female incidence ratio
in ASD.
The paper by Veniaminova et al. places serotonin at
the crossroad of mental and metabolic conditions by
investigating the mechanism through which the reduced
function of the serotonin transporter (SERT or 5-HTT)
contributes to the development of anxiety, depression, and
type-2 diabetes, especially in elderly women. The study
is focused on the metabolic, molecular, and behavioral
consequences of a 3-week exposure of aged female mice
with complete (Sert−/−) or partial (Sert+/−) SERT gene
inactivation to a fat- and sugar-rich diet (“Western Diet,”
WD). All genotypes challenged with WD displayed weight
gain and depressive-like behavior. Interestingly, decreased
glucose tolerance, overexpression of a neuroinflammation
marker, and disrupted hippocampus-dependent performance,
found in the WD-fed wild-type mice, were exacerbated
in Sert−/− mice, but absent in Sert+/− mice. The results
reveal a complex interplay between genetic makeup (SERT
abundancy/function) and environmental factors (type of diet) in
regulating metabolism and behavior during aging. In addition,
the observed resilience of Sert+/− mice to certain environmental
challenges supports the concept of heterosis as an evolutionary
adaptive mechanism.
The study of de Lima et al. starts with the premise
that synergy between the altered 5-HT signaling and adverse
environmental factors in early childhood increases a risk for
behavioral disorders. The authors used a unique approach—
they identified genes co-expressed with 5-HTT in the amygdala
(an emotion-processing brain region) during brain development
and named them a “5-HTT gene network.” They calculated a
polygenic risk score reflecting the function of the 5-HTT gene
network, and studied its interaction with postnatal adversity
in order to predict genome methylation status (a link between
environmental factors and gene expression), cortical density (a
link between expression and function), and attention deficit
hyperactivity disorder (ADHD)-related symptoms (behavioral
outcome presumably underlaid by 5-HT alterations) in pre-
school children. They showed that exposure to postnatal
adversity and decreased function of the 5-HTT gene network
were associated with negative behavioral outcomes and altered
methylation status throughout the genome, and that the 5-
HTT gene network affected gray matter density in brain regions
linked to attentional processes. By revealing the association
of the 5-HTT gene network with vulnerability or resilience
to environmental factors, and indicating the mechanism by
which adversity exerts its effects on attention/hyperactivity, the
results may have implications for both prevention and therapy
of ADHD.
A growing body of evidence highlights the important
contribution of 5-HT to obesity and represents the starting point
of the study by Kesić et al. which explores the mechanism of
this relationship. The authors studied physiological phenotypes
of body weight homeostasis and hypothalamic expression of
body weight–regulating molecules in sublines of rats that
are constitutionally hyper- (high-5HT) or hypo- (low-5HT)
serotonergic. High-5HT animals consumedmore food, displayed
a significant increase in body mass, fat amount, and inner
organ weight, as well as increased hypothalamic expression of
neuropeptide Y receptor and a trend for upregulation of other
orexigenic molecules. The study shows that 5-HT is one of
the endogenous factors contributing to, or protecting from,
becoming obese, presumably by acting both, as a peripheral
(by controlling glucose/lipid metabolism) and a central (by
regulating feeding) signal.
Taken together, the presented papers identified some
of the mechanisms by which developmental disruption
of 5-HT homeostasis, through its complex interplay with
adverse environmental factors and gonadal hormones,
increases vulnerability to behavioral and metabolic
disorders. These findings open new avenues of research
and set paths for the improvement of early diagnostics and
individualized therapy.
AUTHOR CONTRIBUTIONS
DH wrote the first draft, JS and PZ provided critical discussion
and participated in the draft finalization.
FUNDING
DH and JS thank the Croatian Science Foundation (IP-2018-01-
Q146547) for financial support.
Frontiers in Neuroscience | www.frontiersin.org 2 May 2021 | Volume 15 | Article 659356
Hranilovic et al. Editorial: Developmental Abnormalities of Serotonin Homeostasis
REFERENCES
Amireault, P., Sibon, D., and Cote, F. (2013). Life without peripheral serotonin:
insights from tryptophan hydroxylase 1 knockout mice reveal the existence
of paracrine/autocrine serotonergic networks. ACS Chem. Neurosci. 4, 64–71.
doi: 10.1021/cn300154j
Donovan, M. H., and Tecott, L. H. (2013). Serotonin and the
regulation of mammalian energy balance. Front. Neurosci. 7:36.
doi: 10.3389/fnins.2013.00036
Kepser, L. J., and Homberg, J. R. (2015). The neurodevelopmental effects
of serotonin: a behavioural perspective. Behav. Brain. Res. 277, 3–13.
doi: 10.1016/j.bbr.2014.05.022
Nardi, I., De Lucchini, S., Naef, V., and Ori, M. (2017). Serotonin signaling
contribution to an evolutionary success: the jaw joint of vertebrates. Eur. Zool.
J. 84, 19–25. doi: 10.1080/11250003.2016.1269213
Olivier, B. (2014). Serotonin: a never-ending story. Eur. J. Pharmacol. 753, 2–18.
doi: 10.1016/j.ejphar.2014.10.031
Yabut, J. M., Crane, J. C., Green, A. E., Keating, D. J., Khan, W.
I., and Steinberg, G. R. (2019). Emerging roles for serotonin
in regulating metabolism: new implications for an ancient
molecule. Endocr. Rev. 40, 1092–1107. doi: 10.1210/er.2018-0
0283
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Hranilovic, Stefulj and Zill. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Neuroscience | www.frontiersin.org 3 May 2021 | Volume 15 | Article 659356
